Liberum Capital reiterated their buy rating on shares of Udg Healthcare PLC (LON:UDG) in a report released on Wednesday. They currently have a GBX 930 ($12.14) price target on the stock.

UDG has been the topic of several other reports. Numis Securities Ltd cut Udg Healthcare PLC to a hold rating and set a GBX 730 ($9.53) target price on the stock. in a research note on Tuesday, April 4th. Jefferies Group LLC cut Udg Healthcare PLC to a hold rating and raised their target price for the stock from GBX 760 ($9.92) to GBX 785 ($10.25) in a research note on Wednesday, May 24th. Stifel Nicolaus raised their target price on Udg Healthcare PLC from GBX 620 ($8.10) to GBX 650 ($8.49) and gave the stock a hold rating in a research note on Tuesday, April 4th. Berenberg Bank raised their target price on Udg Healthcare PLC from GBX 745 ($9.73) to GBX 800 ($10.45) and gave the stock a hold rating in a research note on Friday, June 23rd. Finally, Peel Hunt raised their target price on Udg Healthcare PLC from GBX 730 ($9.53) to GBX 830 ($10.84) and gave the stock an add rating in a research note on Tuesday, May 23rd. Five equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Udg Healthcare PLC has a consensus rating of Hold and a consensus target price of GBX 781.57 ($10.21).

Udg Healthcare PLC (UDG) opened at 849.50 on Wednesday. The firm’s market capitalization is GBX 2.10 billion. Udg Healthcare PLC has a 52 week low of GBX 567.00 and a 52 week high of GBX 886.50. The stock has a 50 day moving average price of GBX 814.44 and a 200-day moving average price of GBX 722.73.

TRADEMARK VIOLATION NOTICE: “Udg Healthcare PLC (UDG) Stock Rating Reaffirmed by Liberum Capital” was published by Daily Political and is owned by of Daily Political. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2017/07/18/udg-healthcare-plc-udg-stock-rating-reaffirmed-by-liberum-capital.html.

The business also recently disclosed a dividend, which was paid on Tuesday, June 27th. Shareholders of record on Thursday, June 1st were issued a $0.04 dividend. The ex-dividend date was Thursday, June 1st. This represents a yield of 0.35%.

In other Udg Healthcare PLC news, insider Chris Corbin sold 5,650 shares of the firm’s stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of GBX 827 ($10.80), for a total value of £46,725.50 ($61,015.28). Also, insider Jez Moulding acquired 18,000 shares of the stock in a transaction on Wednesday, May 31st. The stock was bought at an average price of GBX 808 ($10.55) per share, with a total value of £145,440 ($189,919.04).

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.

Analyst Recommendations for Udg Healthcare PLC (LON:UDG)

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.